期刊文献+

血清B淋巴细胞刺激因子在系统性红斑狼疮中的意义 被引量:4

Effect of serum B lymphocyte stimulator on patients with systemic lupus erythematosus
原文传递
导出
摘要 目的研究血清B淋巴细胞刺激因子(Blys)在系统性红斑狼疮(SLE)中的意义。方法酶联免疫吸附试验(ELISA)法检测125例SLE患者血清Blys水平,并与狼疮活动程度和临床表现进行相关性分析。结果125例SLE患者血清平均Blys水平显著高于正常对照组[(0.72±0.18)ng,ml vs(0.34±0.10)ng/ml,P=0.0031];SLE患者血清平均Blys水平与SLE疾病活动指数(SLEDAI)积分呈一定程度相关性(r=0.73,P=0.018);SLE患者血清Blys水平与抗dsDNA抗体滴度呈正相关,而与血清IgG、补体、蛋白尿、白细胞、血小板计数,以及皮疹、关节痛、口腔溃疡、脱发、发热等临床表现等均无显著相关性(P>0.05)。结论SLE患者血清Blys水平升高,与狼疮活动呈一定相关性,但不能准确反映病变部位及严重程度。 Objective To study the effect of serum B lymphocyte stimulator (Blys) on patients with systemic lupus erythmatosus (SLE). Methods One hundred and twenty-five SLE patients and 38 normal controls were included into this study. Serum were obtained from all patients and normal controls. The level of Blys were detected in all subjects by enzyme-linked immunosorbent assay (ELISA). Results The level of Blys in serum of 125 case of SLE patients was obviously higher than that in normal controls [ (0.72±0.18)ng/ml vs (0.34±0.10)ng/ml, P=0.0031 ]. There was positive correlation between the level of Blys in serum and SLE Disease Activity Index (SLEDAI) (r=0.73, P=0.018). No statistically significant correlation could be detected between the level of Blys and the titer of IFANA, SSA, SSB, RNP, or Sm antibodies, except for the titer of anti-dsDNA antibody. No significant correlation could be found between the level of Blys and immunoglobulin G, complement, proteinuria, the count of white blood cells and thrombocytes, skin rush, arthritis, mucosal membrane ulcerations, alopecia, fever (P〉0.05). Conclusion High level of Blys could be observed in serum of patients with SLE and somewhat correlated with the lupus acitivity, although the level of Blys in serum can not reflect morbility and mortality of SLE patients.
出处 《中华风湿病学杂志》 CAS CSCD 2007年第7期417-419,共3页 Chinese Journal of Rheumatology
关键词 红斑狼疮 系统性 B淋巴细胞刺激因子 Lupus erythematosus, systemic B lymphocyte stimulator
  • 相关文献

参考文献8

  • 1Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocyte disorders along with autoimmune manifestations. J Exp Med, 1999, 190: 1697-1710.
  • 2Petri M, Stohl W, Chatham W, et al. Association of BLYS with measures of disease activity in a prospective SLE observational study. Arthritis Rheum, 2004, 50: S603.
  • 3Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
  • 4Stohl W, Xu D, Kim KS, et al. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum, 2005, 52: 2080-2091.
  • 5Pers JO, Daridon C, Devauchelle V, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci, 2005, 1050: 34-39.
  • 6Moore PA, Belvedere O, Orr A, et al. BlyS:member of the the tumor necrosis factor family and B lymphocyte stimulator. Science, 1999, 285: 260-263.
  • 7Cheema GS, Roschke V, Hilbert DM, et al. Elevated serum B lymphocyte stimulator in systemic immune-based rheumatic diseases. Arthritis Rheum, 2001, 44: 1313-1319.
  • 8Collins CE, Gavin AL, Migone TS, et al. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates with blood leukocyte BlyS mRNA levels than with plasma BlyS protein levels. Arthritis Res Therapy, 2005, 7: 1186-1198.

同被引文献32

  • 1李东升,王玮蓁,孙春艳,戴明,朱林学,段逸群.系统性红斑狼疮患者B淋巴细胞刺激因子及其受体BAFF-R的表达[J].中华皮肤科杂志,2006,39(1):10-12. 被引量:13
  • 2叶玉津,梁柳琴,许韩师,杨岫岩,詹钟平,连帆,尹培达.IL-10在系统性红斑狼疮患者PBMC B细胞刺激因子表达中的作用[J].中山大学学报(医学科学版),2007,28(1):54-58. 被引量:4
  • 3Moore P A, Belvedere O, Orr A, et al. BlyS: member of the tumor necrosis family and B lymphocyte stimulator [ J ]. Science, 1999, 285 ( 5425 ) :260 - 3.
  • 4Mackay F, Woodcock S A, Lawton P, et al. Mice transgenetic for BAFF develop lymphocytic disorders along with autoimmune mani- festations[J]. J Exp Med, 1999, 190(11) :1697 -710.
  • 5Gross J A, Johnston J, Mudri S, et al. TACI and BCMA are re- ceptors for a TNF homologue implicated in B-cell autoimmune dis- ease[J]. Nature, 2000, 404(6781 ):995-9.
  • 6Collins C E, Gavin A L, Miqone T S, et al. B lymphocyte stimu- lator(BlyS) isforms in systemic lupus erythematosus:disease activ- ity correlates better with blood leukocyte BlyS mRNA levels than with plasma BlyS protein levels[ J]. Arthritis Res Ther, 2006, 8 (1) :R6.
  • 7Pelekanou V, Notas G, Theodoropoulou K, et al. Detection of TN- FSF members BAFF, APRIL, TWEAK and their receptors in nor- real kidney and renal cell carcinomas [ J ]. Anal Cell Pathol, 2011,34(1 -2) :49 -60.
  • 8O' Connor B P, Raman V S, Erikson L D, et al. BCMA is essen- tial for the survival of long-lived bone marrow plasma cells [ J ]. J Exp Med,2004,199 ( 1 ) : 91 - 8.
  • 9Seshasayee D, Valdez P, Yan M, et al. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an in- hibitory BlyS receptor [ J ]. Immunity, 2003,18 ( 2 ) : 279 - 88.
  • 10Sasaki Y, Casola S, Kutok J L, et al. TNF family member B-cell activating factor ( BAFF ) receptor-dependent and-independent roles for BAFF in B cell physiology [ J]. J Immunol, 2004,173 (4) :2245 -52.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部